In the context of cancer, FOXP3 is often associated with the immunosuppressive tumor microenvironment (TME), as its expression correlates with increased Treg infiltration, leading to the inhibition of anti-tumor immunity [13]. This evidence concerns the gene FOXP3 and neoplasm.